Preferred Label : Ranolazine;
MeSH definition : An acetanilide and piperazine derivative that functions as a SODIUM CHANNEL BLOCKER
and prevents the release of enzymes during MYOCARDIAL ISCHEMIA. It is used in the
treatment of ANGINA PECTORIS.;
MeSH synonym : N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide; Renolazine;
MeSH hyponym : Ranolazine Hydrochloride; ranexa; RS 43285; RS 43285-193; Hydrochloride, Ranolazine; Ranolazine Dihydrochloride; Dihydrochloride, Ranolazine; Ranolazine HCl; HCl, Ranolazine; RS 43285 193; RS 43285193; 43285, RS; RS-43285; RS43285;
MeSH Related Number : 110445-25-5; 95635-55-5; F71253DJUN;
Wikipedia link : https://en.wikipedia.org/wiki/Ranolazine;
Is substance : O;
UNII : A6IEZ5M406;
Origin ID : D000069458;
UMLS CUI : C0073633;
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
CISMeF manual mappings
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
An acetanilide and piperazine derivative that functions as a SODIUM CHANNEL BLOCKER
and prevents the release of enzymes during MYOCARDIAL ISCHEMIA. It is used in the
treatment of ANGINA PECTORIS.
https://www.ema.europa.eu/medicines/human/EPAR/ranexa-previously-latixa
2011
false
United Kingdom
French
English
syndication feed
Ranolazine
Ranolazine
tablets
administration, oral
Delayed-Action preparations
drug approval
angina pectoris
treatment outcome
drug labeling
adjuvants, pharmaceutic
adult
aged
drug interactions
breast feeding
pregnancy
drug evaluation, preclinical
ranolazine
summary of product characteristics
package leaflet
drug evaluation
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2011-07/ranexa_-_ct-_9838.pdf
http://www.has-sante.fr/portail/jcms/c_1067925/ranexa
2011
false
France
French
evaluation of the transparency committee
Ranolazine
adult
aged
insurance, health, reimbursement
ranolazine
administration, oral
Delayed-Action preparations
angina pectoris
treatment outcome
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-03/fiche_bum_ranexa.pdf
http://www.has-sante.fr/portail/jcms/c_929460/quelle-place-pour-la-ranolazine-ranexa-dans-langor-stable
2010
true
France
French
Ranolazine
angina, stable
ranolazine
drug interactions
treatment outcome
administration, oral
guidelines for drug use
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-11/ranexa_-_ct-6981.pdf
http://www.has-sante.fr/portail/jcms/c_929091/ranexa-ranolazine-antiangoreux
2009
false
France
French
guidelines for drug use
evaluation of the transparency committee
Ranolazine
Ranolazine
administration, oral
Delayed-Action preparations
ranolazine
angina pectoris
insurance, health, reimbursement
adult
aged
treatment outcome
---
https://www.cadth.ca/sites/default/files/pdf/E0022_Ranolazine_Chronic_Angina_cetap_f.pdf
https://www.cadth.ca/sites/default/files/pdf/E0022_Ranolazine_Chronic_Angina_cetap_e.pdf
2007
false
Canada
French
English
Ranolazine
Ranolazine
chronic pain
angina, stable
controlled clinical trials as topic
treatment outcome
canada
enzyme inhibitors
enzyme inhibitors
drug therapy, combination
Delayed-Action preparations
Evidence-Based medicine
ranolazine
drug evaluation
---
https://www.cadth.ca/sites/default/files/pdf/108_No58_ranolazine_edrug_f.pdf
2004
false
Canada
French
Ranolazine
enzyme inhibitors
clinical trials as topic
angina pectoris
ranolazine
drug evaluation
---